Pills, Profits and Peril: The Underbelly of Big Pharma (Paperback) (ISBN-13: 9798864025475)

Pills, Profit, and Peril: The Underbelly of Big Pharma

"Pills, Profit, and Peril: The Underbelly of Big Pharma" takes readers on a riveting journey into the covert realms of the pharmaceutical industry. This meticulously researched expos? unveils the intricate balance between medical progress and profit, highlighting the often overlooked consequences for the patients these institutions pledge to help.

To many, the pharmaceutical realm stands as a pillar of progress, consistently pioneering novel treatments promising enhanced health and extended life. However, beneath this polished exterior exists a labyrinth of corporate motives, undisclosed intentions, and at times, ethical conundrums. This narrative seeks to cast a light on the lesser-seen facets of this immense industry, scrutinising both its commendable advancements and its challenging setbacks.

Through detailed investigation into historical records, firsthand accounts from industry professionals, and a deep dive into impactful case studies, this book presents a comprehensive yet unsettling view of an industry embroiled in a perpetual struggle between benevolence and greed. From the staggering costs of indispensable medicines and the aggressive promotion of opioids to the withholding of unfavourable clinical trial outcomes and strategic lobbying to mold regulatory standards, "Pills, Profit, and Peril" offers an expansive overview of Big Pharma's far-reaching influence and its profound ramifications on public health.

Highlighted sections of the book encompass:

1. **Behind-the-Scenes Insights: ** Embark on an exploration of the intense world of drug creation and dissemination. Grasp the extensive effort, duration, and assets devoted to ushering a solitary drug into the market and the reasons these often correlate with exorbitant price points.

2. **Ethical Quandaries: ** Navigate the moral predicaments encountered by pharmaceutical entities, especially when the scales tip between profitability and the well-being of patients.

3. **Regulatory Tussles: ** Acquire knowledge about the intricate interplay between pharmaceutical powerhouses and regulatory entities, recognising the mechanisms ensuring drug safety and the potential shortcuts that may be taken.

4. **Worldwide Outlook: ** While the narrative primarily revolves around the Western pharmaceutical sphere, it also touches upon global matters, addressing topics such as drug availability, battles over generic drugs, and the ethics surrounding clinical trials in emerging economies.

5. **Individual Chronicles: ** Interspersed within the book are poignant accounts of patients and their kin, offering a personal perspective to the vast operations of Big Pharma.

"Pills, Profit, and Peril" is more than a mere expos?; it is an invitation to reflect and respond. Urging readers to interrogate and challenge established norms, it serves as a potent reminder that while the medical field operates as a commercial entity, it remains anchored in the venerable commitment to cause no harm. A must-read for healthcare workers, decision-makers, patients, and all who advocate for the fundamental right to health and wellness, this book, with its enthralling tales and extensive research, is set to transform perceptions and interactions within the pharmaceutical domain.